How Tori Spelling and her Daughter Stella Manage Eczema Through Every Season
(BPT) - Tori discusses why addressing eczema symptoms is top of mind as the seasons change
Every year, changing leaves means new routines. Swimsuits are traded for jackets, new backpacks and fresh notebooks are added to the cart - and for millions of families, the checklist includes extra supplies to help children manage eczema symptoms.
Eczema (atopic dermatitis) affects approximately 9.6 million children and 16.5 million adults in the United States. More than dry skin, eczema is a chronic inflammatory skin condition that causes red, intensely itchy rashes that can appear anywhere on the skin.
It's a reality that actress and mom Tori Spelling knows firsthand. Tori lives with eczema herself and is also a caregiver to her daughter Stella (now 18, pictured as a child above), who has had eczema since she was a toddler.
"As a mom of five, our routines don't stop for eczema - carpool, homework, practice, all of it keeps moving," said Tori, mother, actress, best-selling author, executive producer, and successful podcast host. "I know how hard a flare can be, because I've lived it. And watching Stella go through it as a little girl, I felt helpless because nothing we tried seemed to calm her skin."
Like many families, Tori cycled through countless creams and home remedies to try to help Stella with her symptoms. Since atopic dermatitis is a lifelong condition, Tori wanted to find a treatment option that was steroid-free and could be used long-term.
"It was important to me to find a treatment that worked with our daily routine," Tori said. "When our dermatologist recommended ZORYVE® (roflumilast) cream 0.15%, it changed the way we manage our eczema. ZORYVE has helped clear our skin and relieve the itch."
A steroid-free treatment option
ZORYVE cream 0.15% is indicated for the treatment of mild to moderate eczema in adults and children 6 years of age and older. In two clinical trials of over 1,300 people with mild to moderate atopic dermatitis, ZORYVE rapidly improved eczema symptoms such as redness, itching, and rash with once-daily treatment - with nearly a third (31% of the 884 people) achieving clear or almost clear skin at 4 weeks with ZORYVE cream compared to 15% of the 453 people using inactive cream. 32% of 542 people using ZORYVE cream experienced itch relief in 4 weeks vs 17% of 271 people using inactive cream.
For younger children, ZORYVE cream 0.05% is FDA-approved to treat mild to moderate eczema from age 2 to 5, and can be used for any duration, anywhere on the skin. In clinical trials of 652 children, ZORYVE cream 0.05% provided rapid and significant clearance of eczema, with 25% of 437 children using ZORYVE achieving clear or almost clear skin at 4 weeks with ZORYVE cream compared to 11% of 215 children using inactive cream. Additional results, 35% of the 347 children using ZORYVE cream experienced a reduction in itch in 4 weeks, compared to 18% of 160 children using inactive cream as reported by the caregiver.* It is important to note that individual results may vary and it is important to speak to your healthcare provider.
"Eczema is a chronic condition, so patients need treatments they can rely on over the long term," said Dr. Adam Friedman, professor and chair of dermatology at the George Washington University School of Medicine and Health Sciences. "ZORYVE is a once-daily topical treatment for atopic dermatitis formulated without a steroid and without known sensitizers or irritants that can further disrupt the skin barrier. The cream itself has moisturizing properties and it's non-greasy. What's encouraging is how far we've come; just a decade ago, options were limited and we often used medications that were never intended for this extremely common condition. Today, updated American Academy of Dermatology guidelines recognize there are multiple treatment options available, which means we can personalize the decision to the patient. My advice for the new school year is don't dismiss eczema as 'just dry skin,' as just like the translation of its name, it will progressively 'boil up' if not addressed. Talk to a dermatologist about a plan that works for your child."
Tori and Stella have partnered with Arcutis Biotherapeutics on the Free to Be Me awareness campaign to help raise awareness and reduce the stigma around inflammatory skin conditions like eczema.
"Managing eczema is a journey that too many people go on alone," Tori said. "If sharing our story encourages even one family to talk to their doctor - it's worth it."
INDICATIONS AND IMPORTANT SAFETY INFORMATION
Approved Uses
ZORYVE cream 0.15% is a prescription medicine used on the skin (topical) to treat mild to moderate eczema (atopic dermatitis) in adults and children 6 years of age and older.
It is not known if ZORYVE cream 0.15% is safe and effective in children with mild to moderate eczema (atopic dermatitis) younger than 6 years of age.
ZORYVE cream 0.05% is a prescription medicine used on the skin (topical) to treat mild to moderate eczema (atopic dermatitis) in children 2 to 5 years of age.
It is not known if ZORYVE cream 0.05% is safe and effective in children with mild to moderate eczema (atopic dermatitis) younger than 2 years of age and older than 6 years of age.
IMPORTANT SAFETY INFORMATION
ZORYVE is for use on the skin (topical use) only. Do not use ZORYVE in your eyes, mouth, or vagina. Do not use ZORYVE if you have certain liver problems.
Before using ZORYVE, tell your healthcare provider about all of your medical conditions, including if you:
- have liver problems.
- are pregnant or plan to become pregnant. It is not known if ZORYVE will harm your unborn baby.
- are breastfeeding or plan to breastfeed. It is not known if ZORYVE passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with ZORYVE. Breastfeeding women using ZORYVE should use it on the smallest area of the skin and for the shortest time needed. Do not apply ZORYVE directly to the nipple or areola to avoid contact with your baby. Avoid direct skin contact of treated areas with your baby if ZORYVE is applied to your chest.
Tell your healthcare provider about the medicines you take,including prescription and over-the-counter medicines, vitamins, and herbal supplements.
The most common side effects of ZORYVE cream 0.15% in adults and children 6 years of age and older treated for atopic dermatitis include:
- headache
- nausea
- application site pain
- diarrhea
- vomiting
The most common side effects of ZORYVE cream 0.05% in children 2 to 5 years of age treated for atopic dermatitis include:
- upper respiratory tract infections
- diarrhea
- vomiting
- stuffy or runny nose
- red or swollen eyes (like "pink eye")
- headache
These are not all of the possible side effects of ZORYVE. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Please see Patient Information for ZORYVE.
Families don't have to navigate eczema alone. To learn more about eczema and ZORYVE, or to connect with a healthcare provider through the virtual health platform, visit ZORYVE.com.
Photos courtesy of Tori Spelling, a mom, actress, and paid spokesperson for ZORYVE.
*Itch levels in clinical trials of ZORYVE cream 0.05% were tracked and reported by caregivers of children daily. This technique may need more testing to confirm its accuracy in children under 12 years old. Results may vary.
© 2026 Arcutis Biotherapeutics, Inc. All rights reserved.
US-CRP-151-2-00002 10/26
Source: BrandPoint
